Sign In
Buy MRK
$113.87
-1.62 (-1.40%)
At Close: Jun 18, 2026
Merck & Co., Inc. (MRK) BofA Securities 2024 Health Care Conference (Transcript)
10:35pm, Wednesday, 15'th May 2024
Merck & Co., Inc. (NYSE:MRK ) BofA Securities 2024 Health Care Conference May 15, 2024 4:40 PM ET Company Participants Caroline Litchfield - EVP & CFO Conference Call Participants Geoff Meacham - Bank
2 Fortune 100 Best Co's To Work For Are Also Good To Own
03:37pm, Wednesday, 15'th May 2024
2 Fortune 100 Best Co's To Work For Are Also Good To Own
Trade Tracker: Joe Terranova buys Amgen and Merck
01:03pm, Wednesday, 15'th May 2024
Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to detail his latest buys
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck to Present New Data at 2024 ASCO Demonstrating Advancements in Novel Oncology Treatment Approaches Across Broad Portfolio and Diverse Pipeline.
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
10:25am, Tuesday, 14'th May 2024
Merck (MRK) discontinues the Keytruda plus vibostolimab co-formulation arm of a phase III study due to a higher rate of patient discontinuation.
Merck stops skin cancer combination therapy testing in late-stage study
07:09am, Monday, 13'th May 2024
Merck said on Monday it had discontinued the arm of a late-stage study, which tested an experimental antibody-based drug with its blockbuster immunotherapy Keytruda for some patients with the most sev
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Update on KeyVibe-010 Evaluating Coform of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients W/ Resected High-Risk Melanoma.
5 April Quality Dividend Growth Stock Raises
08:55am, Sunday, 12'th May 2024
5 companies in Rose's Income Garden portfolio gave April raises, spanning different sectors including consumer staples, healthcare, utility, technology, and real estate. The raises varied in percentag
JP Morgan Has 5 Blue Chip Passive Income Stocks as Top Picks for May
08:53am, Saturday, 11'th May 2024
If you want your portfolio to pay you cash like clockwork, it's time to stop blindly following conventional wisdom like relying on Dividend Aristocrats.
Merck: The Worst Has Been Avoided (Rating Upgrade)
06:02am, Friday, 10'th May 2024
On April 25, one of the leaders in the global oncology drugs market published extremely positive financial results for the first quarter of 2024. Keytruda sales were about $6.95 billion in the first q
The 3 Most Undervalued Healthcare Stocks to Buy in May 2024
06:01am, Friday, 10'th May 2024
A commonly used strategy for investing is sector rotation. This involves the movement of funds from one sector to another based on macroeconomic and other factors.
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
10:34am, Thursday, 09'th May 2024
Investors are well aware of the explosive growth potential in weight loss drug stocks. That growth began last year with Eli Lilly (NYSE: LLY ) and Novo Nordisk (NYSE: NVO ).
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
10:06am, Thursday, 09'th May 2024
Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.
Merck treatment for a type of uterus cancer fails trial
06:57am, Thursday, 09'th May 2024
Merck said on Thursday its treatment for a type of uterus cancer did not meet the main goal of disease-free survival in a late-stage trial.
Merck to Participate in the Bank of America Securities 2024 Healthcare Conference
06:45am, Wednesday, 08'th May 2024
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck to Participate in the Bank of America Securities 2024 Healthcare Conference.
